Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jorma Paavonen. (2012) Chlamydia trachomatis infections of the female genital tract: State of the art. Annals of Medicine 44:1, pages 18-28.
Read now
Read now
Sarah Woodhall, Tiina Eriksson, Anna-Mari Nykänen, Heini Huhtala, Pekka Rissanen, Dan Apter, Jorma Paavonen & Matti Lehtinen. (2011) Impact of HPV vaccination on young women's quality of life – A five year follow-up study. The European Journal of Contraception & Reproductive Health Care 16:1, pages 3-8.
Read now
Read now
Franco Maria Buonaguro, Maria Lina Tornesello & Luigi Buonaguro. (2009) Virus-like particle vaccines and adjuvants: the HPV paradigm. Expert Review of Vaccines 8:10, pages 1379-1398.
Read now
Read now
Articles from other publishers (19)
L.-H. Wei, Y.-Y. Su, Y.-M. Hu, R.-C. Li, W. Chen, Q.-J. Pan, X. Zhang, F.-H. Zhao, Y.-Q. Zhao, Q. Li, Y. Hong, C. Zhao, M.-Q. Li, W.-Y. Liu, C.-H. Li, D.-P. Guo, L.-D. Ke, B.-Z. Lin, Z.-J. Lin, S. Chen, W. Sheng, Z.-Z. Zheng, S.-J. Zhuang, F.-C. Zhu, H.-R. Pan, Y.-M. Li, S.-J. Huang, J. Zhang, Y.-L. Qiao, T. Wu & N.-S. Xia. (2020) Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18–45 years enrolled in a clinical trial. Clinical Microbiology and Infection 26:8, pages 1069-1075.
Crossref
Crossref
Nicolas F. Schlecht, Angela Diaz, Viswanathan Shankar, Arnold H. Szporn, Maoxin Wu, Anne Nucci-Sack, Ken Peake, Howard D. Strickler & Robert D. Burk. (2016) Risk of Delayed Human Papillomavirus Vaccination in Inner-City Adolescent Women. Journal of Infectious Diseases 214:12, pages 1952-1960.
Crossref
Crossref
Raúl Murillo, Rolando Herrero, Mónica S. Sierra & David Forman. (2016) Cervical cancer in Central and South America: Burden of disease and status of disease control. Cancer Epidemiology 44, pages S121-S130.
Crossref
Crossref
Albert Zeyer, Daniel M. Levin & Alla Keselman. 2015. Meeting Health Information Needs Outside Of Healthcare. Meeting Health Information Needs Outside Of Healthcare
235
261
.
Alan R. Shaw. (2013) Human Papillomavirus Vaccines Six Years After Approval. Annual Review of Medicine 64:1, pages 91-100.
Crossref
Crossref
Edith Roset Bahmanyar, Jorma Paavonen, Paulo Naud, Jorge Salmerón, Song-Nan Chow, Dan Apter, Henry Kitchener, Xavier Castellsagué, Julio C. Teixeira, S. Rachel Skinner, Unnop Jaisamrarn, Genara A. Limson, Suzanne M. Garland, Anne Szarewski, Barbara Romanowski, Fred Aoki, Tino F. Schwarz, Willy A.J. Poppe, Newton S. De Carvalho, Diane M. Harper, F. Xavier Bosch, Alice Raillard, Dominique Descamps, Frank Struyf, Matti Lehtinen & Gary Dubin. (2012) Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. Gynecologic Oncology 127:3, pages 440-450.
Crossref
Crossref
Jennifer S. Smith, Adam K. Lewkowitz, You‐Lin Qiao, Jia Ji, Shangying Hu, Wen Chen, Rong Zhang, Kai Li Liaw, Mark Esser, Frank J. Taddeo, Robert G. Pretorius & Jerome L. Belinson. (2012) Population‐based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women. International Journal of Cancer 131:6, pages 1388-1395.
Crossref
Crossref
A. Szarewski, W.A.J. Poppe, S.R. Skinner, C.M. Wheeler, J. Paavonen, P. Naud, J. Salmeron, S.‐N. Chow, D. Apter, H. Kitchener, X. Castellsagué, J.C. Teixeira, J. Hedrick, U. Jaisamrarn, G. Limson, S. Garland, B. Romanowski, F.Y. Aoki, T.F. Schwarz, F.X. Bosch, D.M. Harper, K. Hardt, T. Zahaf, D. Descamps, F. Struyf, M. Lehtinen & G. Dubin. (2011) Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18. International Journal of Cancer 131:1, pages 106-116.
Crossref
Crossref
Rongcheng Li, Yanping Li, David Radley, Youping Liu, Teng Huang, Heather L. Sings, Lingling Zhang, Wei Wang, Xiang Zhong & Alfred J. Saah. (2012) Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: A randomized, double-blind, placebo-controlled trial in Chinese males and females. Vaccine 30:28, pages 4284-4291.
Crossref
Crossref
Nicolas F. Schlecht, Robert D. Burk, Anne Nucci-Sack, Viswanathan Shankar, Ken Peake, Elizabeth Lorde-Rollins, Richard Porter, Lourdes Oriana Linares, Mary Rojas, Howard D. Strickler & Angela Diaz. (2012) Cervical, Anal and Oral HPV in an Adolescent Inner-City Health Clinic Providing Free Vaccinations. PLoS ONE 7:5, pages e37419.
Crossref
Crossref
Sarah M. Tiggelaar, Margaret J. Lin, Raphael P. Viscidi, Jia Ji & Jennifer S. Smith. (2012) Age-Specific Human Papillomavirus Antibody and Deoxyribonucleic Acid Prevalence: A Global Review. Journal of Adolescent Health 50:2, pages 110-131.
Crossref
Crossref
Joseph Monsonego. (2011) Response to Letter to the Editor by Tsu et al. “Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine”. Vaccine 29:50, pages 9292-9293.
Crossref
Crossref
Sarah Coseo, Carolina Porras, Allan Hildesheim, Ana Cecilia Rodriguez, Mark Schiffman, Rolando Herrero, Sholom Wacholder, Paula Gonzalez, Sophia S. Wang, Mark E. Sherman, Silvia Jimenez, Diane Solomon, Catherine Bougelet, Leen-Jan van Doorn, Wim Quint & Mahboobeh Safaeian. (2010) Seroprevalence and Correlates of Human Papillomavirus 16/18 Seropositivity Among Young Women in Costa Rica. Sexually Transmitted Diseases 37:11, pages 706-714.
Crossref
Crossref
J. Monsonego, J. Cortes, C. Greppe, M. Hampl, E. Joura & A. Singer. (2010) Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine. Vaccine 28:51, pages 8065-8072.
Crossref
Crossref
J. Monsonego. (2010) Cancer anal et papillomavirus humains : une pathologie en miroir de celle du cancer du col utérin. Gynécologie Obstétrique & Fertilité 38:4, pages 250-254.
Crossref
Crossref
Eduardo Lazcano-Ponce & Betania Allen-Leigh. (2009) Innovation in Cervical Cancer Prevention and Control in Mexico. Archives of Medical Research 40:6, pages 486-492.
Crossref
Crossref
Elisabeth Barthell, Linn Woelber, Karin Hellner, Birka Camerer, Friederike Gieseking, Maik Hauschild, Ioannis Mylonas, Klaus Friese, Heather L. Sings, Radha Railkar, Christine Gause & Eliav Barr. (2008) Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6/11/16/18) vaccine. Archives of Gynecology and Obstetrics 279:6, pages 803-807.
Crossref
Crossref
Peter K. Kohl. 2009. Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie
216
222
.
Lucia Six, Sepp Leodolter, Heather L. Sings, Eliav Barr, Richard Haupt & Elmar A. Joura. (2008) Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women – baseline data of a phase III vaccine trialDie Prävalenz der Infektion durch Humane Papilloma Viren (HPV) 6, 11, 16, 18 bei Frauen zwischen 16 und 24 Jahren in Österreich – Österreichische Daten einer Phase III Studie zur Testung eines quadrivalenten Impfstoffes gegen HPV 6, 11, 16, 18. Wiener klinische Wochenschrift 120:21-22, pages 666-671.
Crossref
Crossref